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Abstract 
Purpose 
To establish whether objective measurements of symmetry of volume and 
shape using three dimensional surface imaging (3D-SI) can be used as 
surrogate markers of aesthetic outcome in patients who have undergone 
breast conserving therapy (BCT). 
Methods 
Women who had undergone unilateral BCT in the preceding 1 to 6 years 
were invited to participate. Participants completed a satisfaction 
questionnaire (BREAST-Q) and underwent 3D surface imaging (3D-SI). 
Volume and surface symmetry were measured on the images. Assessment 
of aesthetic outcome was undertaken by a panel of clinicians. The Kruskal 
Wallis test was used to assess the relationship between volume and shape 
symmetry measurements with the panel score. Spearman’s rho correlations 
were used to assess the relationship between the measurements and patient 
satisfaction. 
Results 
200 women participated. Median volume symmetry was 87% (IQR 78-93) 
and shape symmetry was 5.9mm (IQR 4.2-8.0).   
The participants were grouped according to panel assessment of aesthetic 
outcome (poor, fair, good, excellent) and the median volume and shape 
symmetry was calculated for each group. Volume symmetry significantly 
differed between the groups. Post hoc pairwise comparisons demonstrated 
these differences existed between panel scores of fair versus good, and 
good versus excellent. 
Median shape symmetry also differed according to patient panel groups. 
However there were four significant pairwise comparisons between poor 
versus good, poor versus excellent, fair versus good and fair versus 
excellent.   
There was a significant but weak correlation of both volume symmetry and 
surface asymmetry with BREAST-Q scores (correlation coefficients 0.187 
and -0.229 respectively). 
Conclusion 
Breast volume and shape symmetry are both associated with panel 
assessment scores and patient satisfaction. The objective volume and shape 
symmetry measures were strongly associated with panel assessment 
scores, such that a 3D-SI tool could replace panel assessment as a faster 
and more objective method of evaluating aesthetic outcomes. 
 
 
  
Introduction 
In the UK, around 30,000 women per year undergo breast conserving 
treatment (BCT) for breast cancer(1). The combination of surgery and 
radiotherapy has achieved good local control rates (2, 3) and is equivalent to 
mastectomy. However, the technical challenges of completely excising 
tumour whilst also re-shaping breast tissue to provide an aesthetically 
acceptable outcome yield variable cosmetic results and variable patient 
satisfaction. Therefore, although the long term success of BCT is measured 
primarily by local control, increased survivorship (87% at 5 years) (4), 
demands that the physical and psychological effects of treatment, especially 
long term effects, are addressed. Dissatisfaction with the appearance after 
treatment acts as a constant reminder of the disease and affects a woman’s 
psychological wellbeing (5-7).  
Assessment of aesthetic outcome has, to date, remained a challenge for 
breast and plastic surgeons alike. There is no gold standard or consensus on 
which factors should be assessed and who should undertake the analysis 
(8). The mainstays of assessment are subjective, using either patient-
reported outcome measures (PROMs) (9-12) or panel assessment of 
appearance (13, 14). More recently, objective assessments have been 
developed in the form of the Breast Analysing Tool (BAT©) (15) and the 
Breast Cancer Conservative Treatment cosmetic result software 
(BCCT.core) (16, 17) whereby a single photograph (anterior view) of the 
patient is analysed to give an aesthetic outcome score between 1 and 4. 
Three dimensional surface imaging (3D-SI) has been used as a marketing 
tool in aesthetic breast surgery. Three dimensional (3D) images are taken 
and manipulated to illustrate to potential patients how they may appear after 
augmentation or mammoplasty/mastopexy. A survey of 1067 plastic 
surgeons in America revealed that 15% of surgeons are using 3D-SI 
technology in their practice (18). We have reported on the use of  3D-SI as a 
research and clinical tool in aesthetic, oncoplastic and reconstructive breast 
surgery (19) using linear distances and 3D measurements such as volume 
and symmetry. Several other studies have validated its use in volume 
measurement (20-29) as a surgical planning tool.  The aim of this study was 
to establish whether symmetry of volume and shape on 3D-SI following BCT 
can be used as surrogate markers of aesthetic outcome (as judged by a 
panel assessment or by PROMs). 
Methods 
Patient recruitment 
Research Ethical Committee (REC) approval was obtained 
(ClinicalTrials.gov Identifier: NCT02304614). Women aged ≥18 years who 
had undergone BCT (wide local excision and adjuvant whole breast 
radiotherapy) for an invasive or in-situ carcinoma in our unit (four permanent 
surgeons) between one and six years before the start of the study met the 
inclusion criteria. The following patients were excluded: those who developed 
recurrent (local or distant) disease since BCT, those who had previously or 
subsequently undergone surgery to the index or contralateral breast and 
those who were unable to undergo 3D-SI (e.g. unable to stand for 5 
minutes). 
Patients were invited to participate in the study by letter, followed up by a 
telephone call. Those who agreed to participate were offered an appointment 
for 3D-SI before or after their mammogram or at another mutually convenient 
time. The 3D-SI images were taken in the medical photography department.  
Data Acquisition 
3D-SI breast imaging  
Participants were imaged using the Vectra-XT 3D-SI system with their hands 
on hips.  Volume symmetry was calculated by dividing the volume of the 
smaller breast by the volume of the larger breast and converting to a 
percentage value. The closer the result to 100, the more symmetrical the 
breasts were in terms of volume. Shape symmetry was calculated by 
bisecting the 3D image vertically along the midline and reflecting the image 
of the left breast onto the right. The root mean squared (RMS) of the 
distances between the two superimposed breast surfaces was calculated in 
millimetres. (Figure 1). The lower the score the more symmetrical the breasts 
are in terms of shape. 
Panel assessment 
The panel consisted of four members, two breast surgeons, one clinical 
oncologist and one breast care nurse. Panellists were asked to rate the 
participants’ images according to the 4-point Harvard cosmesis scale (Table 
1). Initially the scoring system was to assess the effect of radiotherapy (13) 
but has since been adapted to a cosmetic outcome (30). The 3D images 
were rotated so they could be reviewed from either side, cranially looking 
downwards towards the cleavage and caudally upwards from the feet 
towards the inferior mammary fold (IMF). The panel scored independently 
and then the opinion of the majority was assigned as a consensus score. If 
there was disparity in scoring, the images a discussion ensued to reach a 
consensus; the method used in other studies with a cosmetic outcome 
endpoint (31-33). To evaluate the test-retest variation, 10% of all the images 
were randomly shown twice and the two scores compared to provide an 
estimate of test-retest reliability.  
Patient satisfaction 
The BREAST-Q is a questionnaire devised by the Memorial Sloan-Kettering 
Cancer Center to elicit and quantify patient perception of outcomes after 
breast surgery (12, 34). It has been developed using extensive patient input 
and Rasch psychometric methods (35, 36) to measure patient satisfaction 
and quality of life. Modules have been developed for patients undergoing 
mastectomy, breast reconstruction and most recently Breast Conserving 
Therapy (BCT).  This module contains eight domains. However, only the 
‘Satisfaction with breasts’ domain and some of its sub-questions were used 
in this study. Each domain contains sub-questions and the ‘raw’ score is 
transformed to a score ranging from 0-100, where a higher score indicates 
greater satisfaction. We have previously reported results of all of the 
domains of the BREAST-Q BCT module (37). 
Statistical analysis 
Demographics were presented as descriptive statistics using mean and 
standard deviation or median and IQR range, as appropriate, after testing for 
normality. Categorical data were presented as proportions and frequencies 
with 95% confidence intervals (CIs) where appropriate. 
The Kruskal Wallis test was used to assess the relationship between 
categorical (e.g. panel assessment, sub-questions from ‘Satisfaction with 
breasts’) and continuous variables (e.g. volume symmetry, shape symmetry, 
‘Satisfaction with breasts’), after testing for normality. The Dunn Sidak test (a 
post hoc adjusted pairwise comparison) was used to identify between which 
pairs of categorical results the significant differences lay. Any pairwise 
comparisons with a P<0.05 were considered statistically significant. 
Spearman’s rho correlations were used to assess the relationship between 
two continuous variables after testing for normality. A correlation coefficient 
result between 0.00-.019 indicates very weak correlation, 0.20-0.39 is weak, 
0.40-0.59 is moderate, 0.60-0.79 is strong and 0.80-1.0 is very strong. 
A kappa statistic was used for comparison of two categorical datasets.   
A value of 0 indicates no agreement, 0–0.20 is slight, 0.21–0.40 is fair, 0.41–
0.60 is moderate, 0.61–0.80 is substantial, is 0.81–1 is almost perfect. 
Analysis was undertaken using STATA (STATA, Inc., Texas). 
Results 
Between 01/04/2015 and 31/10/2015, 649 women were scheduled to have a 
surveillance mammogram. Three hundred and forty two (53.7%) women 
were eligible and had a mammogram booked at a time when the investigator 
(ROC) was available. All were invited but 109 were not contactable by phone 
to confirm participation. Of the 233 women who were contactable, 206 
(88.4%) agreed to participate and 27 (11.6%) declined. In total, 200 (85.8%) 
women participated. The clinicopathological characteristics of the study 
population are summarised in Table 2. 
Median panel score was 3 (IQR 2-4). Eight (4%) participants were assigned 
a panel score of poor, 62 (31%) scored fair, 78 (39%) scored good and 52 
(26%) scored excellent. For the 10% test-retest validation of the panel 
assessment the weighted agreement was 98.3%, Kappa 0.96 (almost 
perfect), (P<0.001). Median score for ‘Satisfaction with breasts’ was 69.5 
(IQR 31-100).  
The median treated breast volume was 456 cm3 (IQR 323-680 cm3), median 
untreated breast volume was 493 cm3 (IQR 340-740 cm3). The median 
volume symmetry was 87% (IQR 78-93%) (Figure 2). The median shape 
symmetry, RMS, was 5.9 mm (IQR 4.2-8.0 mm) (Figure 3). 
Relationship between objective 3D-SI measurements of volume and 
shape symmetry with panel assessment 
I) Volume symmetry 
The median volume symmetry measurements differed between panel 
assessment groups (Kruskal Wallis test, P=0.028) (Table 3). Post hoc 
pairwise comparison using Dunn Sidak test further demonstrated that these 
differences existed between panel scores ‘fair’ and ‘good’, as well as 
between ‘fair’ and ‘excellent’ (Figure 4).Participants deemed ‘poor’ by the 
panel did not have a significantly different volume symmetry from those 
deemed ‘good’ (p=0.645) or ‘excellent’ (p=0.528). This indicates that a ‘poor’ 
panel assessment did not necessarily relate to volume symmetry but may be 
biased by the very small numbers of patients in this category.  
II) Shape symmetry 
The median shape symmetry measurements differed between panel 
assessment groups (Kruskal Wallis test, P<0.001) (Table 3). Post hoc 
pairwise comparison using the Dunn Sidak test further demonstrated that 
these differences arose between panel scores ‘poor’ and ‘good’, ‘poor’ and 
‘excellent’, ‘fair’ and ‘good’ as well as ‘fair’ and ‘excellent’ (Figure 5). This 
indicates that shape symmetry was always significantly different between 
those assigned a poor or fair score and those considered to be good or 
excellent. 
Relationship between objective 3D-SI measurements of volume and 
shape symmetry with patient satisfaction  
I) Volume symmetry 
There was a significant positive correlation between volume symmetry 
measurements and ‘Satisfaction with breasts’ scores however the correlation 
was very weak (Spearman’s correlation coefficient = 0.187, P=0.008, r2 = 
0.033).  
II) Shape symmetry 
There was a significant negative correlation between shape symmetry 
measurements and ‘Satisfaction with breasts’ scores however the correlation 
coefficient was also weak (Spearman’s correlation coefficient = -0.229, 
P=0.001, r2 = 0.079).  
Objective volume symmetry and ‘Satisfaction with breasts’ sub-
question ‘How equal in size your breasts are to each other?’ 
Due to the nature of ‘Satisfaction with breasts’ being a global outcome score 
the 3D volume and shape symmetry were tested against participants’ 
perceptions using the sub-questions relating to volume and symmetry. 
The median volume symmetry measurements differed between groups 
according to patient reported score for ‘How equal in size your breasts are to 
each other’ (Kruskal Wallis test, P<0.001). Post hoc pairwise comparison 
using Dunn Sidak test further demonstrated there were significant 
differences between participants’ scores for equality of size ‘very dissatisfied’ 
and ‘very satisfied’ (p=0.046), ‘somewhat dissatisfied’ and ‘somewhat 
satisfied’ (p=0.008), ‘somewhat dissatisfied’ and ‘very satisfied’ (p=0.006) 
(Table 4). This indicates that participants who were ‘very satisfied’ with how 
equal in size their breasts are had significantly better volume symmetry than 
those who answered ‘very dissatisfied’ or ‘somewhat dissatisfied’. 
Objective surface symmetry and ‘Satisfaction with breasts’ sub-
question ‘How much your breasts look the same?’ 
The median shape symmetry measurements were significantly different 
according to patient reported score for ‘How much your breasts look the 
same’ (Kruskal Wallis test, P<0.001). Post hoc pairwise comparison using 
Dunn Sidak test further demonstrated that these differences arose between 
participants’ scores ‘very dissatisfied’ and ‘somewhat satisfied’ (p=0.017), 
‘very dissatisfied’ and ‘very satisfied’ (p<0.001), ‘somewhat dissatisfied’ and 
‘very satisfied’ (p=0.002), ‘somewhat satisfied’ and ‘very satisfied’ (p=0.002) 
(Table 4). This indicates that participants who were ‘very satisfied’ that their 
breasts look the same had a greater objective symmetry compared to 
participants who rated it as ‘very dissatisfied’, ‘somewhat dissatisfied’ and 
‘somewhat satisfied’. 
Discussion 
This study shows that 3D measures of volume and shape symmetry agree 
with panel assessment and to a lesser extent with PROMs, indicating that 3D 
surface imaging could contribute to an objective measure of aesthetic 
outcome. Currently the mainstays of analysis of aesthetic outcome are panel 
assessment of 2D photographs and objective scoring software using 2D 
photographs. Panel assessments have limitations in the time and manpower 
required. Furthermore, they are difficult to standardise and there is no 
assurance that, even if the same scale is used, two panels would score with 
identical strictness or leniency. Objective analysis offers a potential solution 
but 2D photographs may not provide the ‘whole story’ due to the very nature 
of analysing a three dimensional object in two dimensions. For example, 2D 
photographs do not demonstrate the projection and cleavage well, whereas 
in 3D-SI the image of the patient can be rotated to view the cleavage and 
allow the reviewer to see the patient as she sees herself.  
Patients also provide insight into their own assessment of the aesthetic 
outcome with PROMs, and this is a key outcome measure. However, there 
may be many confounding factors in the patients’ responses due to their pre-
morbid state and the psychological impact of diagnosis and treatment of 
breast cancer such that PROMs alone cannot be used in evaluation of new 
surgical or radiotherapy techniques. We have shown that 3D-SI can 
contribute to these evaluations.  
In this study there were only two significant pairwise comparisons of volume 
symmetry out of a possible seven when assessing its relationship with panel 
assessment. It is possible that surgery and radiotherapy lift the breast on the 
chest wall so that the panel assessment of symmetry is poor but the 
objective volume symmetry is relatively good. Similarly a patient may have a 
focal deformity, drawing the reviewer’s attention resulting in a low panel 
score but the overall objective volume is similar to the unaffected breast. 
Finally the low association found between panel and volume symmetry may 
also have been due to the panel method used as the Harvard classification 
focuses on symmetry and deformity of the breasts rather than volume.  
There was a better association between objective shape symmetry and 
panel score with four significant pairwise comparisons. Shape symmetry 
encompasses volume as part of the whole, just as a panel will evaluate 
appearance more globally and the Harvard score focuses on symmetry so it 
is unsurprising that there was a better association with shape than with 
volume symmetry. Our findings are in keeping with those of Henseler et al 
(38) who found a significant relationship between the mean subjective panel 
assessment score and objective symmetry (correlation coefficient -0.62) 
when assessing forty-four patients who had undergone unilateral extended 
latissimus dorsi flap reconstruction.  
Volume symmetry and shape symmetry were both correlated with patient 
‘Satisfaction with breasts’. However these correlations were weak such that 
these objective measurements are unlikely to replace a patient’s perception 
of aesthetic outcome.  The patient satisfaction domain of the BREAST-Q 
encompasses many aspects of how the patient feels about the aesthetic 
outcome and, as mentioned previously, many biases can confound a 
patients’ satisfaction other than pure aesthetic outcome. These results may 
also reflect the way in which the BREAST-Q module was developed and it 
could be that volume and symmetry had low weighting in the overall scoring 
compared to other factors, for example how the patient feels unclothed in the 
mirror. To assess this further we investigated the relationship between the 
sub-question ‘How equal in size your breasts are to each other’ and volume 
symmetry. There were three significant pairwise comparisons indicating that 
patients’ subjective assessment on a 4 point scale correlates well with 
objective assessment of volume symmetry. Sub-question ‘How much your 
breasts look the same’ demonstrated even better association with shape 
symmetry, with four pairwise comparisons. A similar study was undertaken 
by Yip et al (39) where 119 women who had undergone immediate or 
delayed breast reconstruction underwent 3D-SI and answered the BREAST-
Q post-operative reconstruction module. Unlike this study, they found no 
correlation between volume symmetry and ‘Satisfaction with breasts’ but they 
did find that patients were able to perceive volume difference on answering 
the sub-questions. The authors did not assess shape symmetry. The 
heterogeneity of their patient population may account for the difference in 
results between their study and ours. 
We believe that 3D-SI will have an important role in the evaluation of breast 
surgery and radiotherapy in the future. As the technology evolves to become 
more portable and lower cost, (40-44) it will be available to more units 
treating patients with breast cancer, and could be used as a robust outcome 
tool in multicentre surgical and radiotherapy studies as well as in internal 
audits and quality assurance studies. 
Conclusion 
Breast volume and shape symmetry measured using 3D-SI are both 
associated with panel assessment of breast appearance and patient 
satisfaction with the cosmetic outcome. Shape symmetry, in particular, 
showed greatest association with panel assessment, such that it may be 
possible to replace this with an objective outcome score encompassing 
shape symmetry and other parameters measured using 3D-SI. 
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 Figure 1. Example of calculation of shape symmetry using the root mean squared (RMS). 
Reproduced with the permission of Canfield Scientific. The left breast image is reflected onto 
the right. In the first image a geometric pattern is applied to one breast image. The 
perpendicular distances from all the interception points of the grid to the other breast is 
calculated (second and third image).  
 
Figure 2. Frequency distribution of volume symmetry 
 Figure 3. Frequency distribution of shape symmetry, root mean squared (RMS) 
 
Figure 4. Box and whisker plot demonstrating volume symmetry (%) according to consensus 
panel assessment of aesthetic outcome. The horizontal lines within each box represent 
median scores, the outer horizontal lines of each box represent upper and lower quartiles, 
and the ends of the vertical lines represent minimum and maximum scores. On post-hoc pair 
wise comparisons there was a significant difference in volume symmetry when comparing 
‘fair’ with ‘good’ and ‘good’ with ‘excellent’ panel scores. The other comparisons were not 
significant. 
 Figure 5. Box and whisker plot demonstrating shape symmetry RMS, mm) according to 
consensus panel assessment of aesthetic outcome. The horizontal lines within each box 
represent median scores, the outer horizontal lines of each box represent upper and lower 
quartiles, and the ends of the vertical lines represent minimum and maximum scores. On 
post-hoc pair wise comparisons there was a significant difference in shape symmetry when 
comparing poor with good, poor with excellent, fair with good and fair with excellent. The 
other comparisons were not significant. 
Outcome Description Score 
Excellent Treated breast nearly identical to untreated breast. 4 
Good Treated breast slightly different from untreated breast. 3 
Fair Treated breast clearly different from untreated breast but 
not seriously distorted. 
2 
Poor Treated breast seriously distorted. 1 
Table.1. 4-point Harvard cosmesis scale. 
Clinicopathological data Study population 
Pre-operative data 
Age at time of surgery (years), mean (SD) 64.2 (10.1) 
Time from surgery to study participation (months), mean (SD) 35.6 (17.7) 
Ethnic origin 
White 
Non-white 
 
186 (93%) 
14 (7%) 
Smoking status (%) 
Never 
Current 
Ex-smoker 
 
119 (59.5) 
16 (8) 
65 (32.5) 
BMI at surgery (kg/m2), mean (SD) 27.5 (5.4) 
Location of tumour on pre-operative imaging (%) 
Upper Outer 
Central 
Lower inner 
 
109 (54.5) 
8 (4) 
27 (13.5) 
Clinicopathological data Study population 
Lower outer 
Upper Inner 
21 (10.5) 
35 (17.5) 
Ultrasound size (mm), mean (SD) 13.9 (8.6) 
Mammographic size (mm), mean (SD) 16.26 (10.88) 
Intra-operative data 
Type of surgery (%) 
WLE 
Other complex breast conservation 
 
181 (90.5) 
19 (9.5) 
Axillary surgery (%) 
Nil 
SLNB or sampling 
ALND 
 
19 (9.5) 
150 (75) 
31 (15.5) 
Re-excision of margins (%) 
No 
Yes 
 
169 (84.5) 
31 (15.5) 
Pathology data 
Tumour pathology size including DCIS (mm), mean (SD) 21.6 (13.1) 
Weight of specimen (g), median (IQR) 32.5 (20-49) 
Adjuvant therapy 
Adjuvant chemotherapy (%) 
No 
Yes 
 
161 (80.5) 
39 (19.5) 
Endocrine Therapy (%) 
No 
Yes 
 
30 (15) 
170 (85) 
Whole breast radiotherapy (%) 
No 
Yes 
 
0 
200 (100) 
Boost radiotherapy (%) 
No 
Yes 
 
149 (74.5) 
51 (25.5) 
Table 2. Summary of study participants’ clinicopathological characteristics.  
  
Panel 
assessment 
consensus 
scores Number 
 
Volume 
symmetry (%) 
Median (IQR) 
 
Shape symmetry 
(RMS) 
Median (IQR) 
1=Poor 8 85.6 (75.3-90.7) 9.7 (6.5-13.2) 
2=Fair 62 83.1 (72.2-92) 7.9 (6.4-9.8) 
3=Good 78 88.2 (80.6-93.8) 5.2 (4-7.2) 
4=Excellent 52 89.7 (81.3-93.6) 4.6 (3.4-6) 
Total 200 87 (78.1-93.4) 5.9 (4.2-8) 
Table 3. Volume and shape symmetry according to 3D-SI panel scores. 
 
 
Sub-question Likert 
scale 
With your breasts in mind, in the past 2 weeks, how 
satisfied or dissatisfied have you been with: 
How equal in size your 
breasts are to each other? 
How much your breasts 
look the same? 
Numbe
r 
Median volume 
symmetry (%) 
Median (IQR)  
Number 
Median shape 
symmetry 
(RMS) 
Median (IQR) 
1=Very dissatisfied  11 78.1 (71.1-82.3) 13 7.8 (7.2-10.4) 
2=Somewhat 41 79.9 (69.8-89.4) 40 6.4 (4.6-9.1) 
dissatisfied  
3=Somewhat satisfied  87 89 (81.7-93.8) 93 6.1 (4.6-8.1) 
4=Very satisfied  61 89.8 (80.9-93.6) 54 4.6 (3.4-6.3) 
Total 200 87 (78.1-93.4) 200 5.9 (4.2-8) 
Table 4. Volume symmetry according to ‘How equal in size your breasts are to each other?’ 
and shape symmetry according to ‘How much your breasts look the same?’ 
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